Tag Archives: Pfizer’s

Pfizer’s COVID-19 booster vaccine, pneumococcal jab tested in older adults

The first participants aged 65 and older have received vaccinations in a new study assessing coadministration of a pneumococcal jab along with a COVID-19 booster shot, Pfizer announced on Monday. Trial investigators are aiming to study the safety and resulting immune response, following participants up to six months post-vaccination. The trial involves 600 adults recruited… Read More »